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Q/LM potencies: Historical reasons for the long delay 
in their recognition 
In spite of great endeavours by the homeopathic 
community towards excellence, evidence, and quality 
control in homeopathy's theory and practice there is 
still plenty of obscurities and white patches-chal-
lenges for explorers- left. One of several under 
researched issues still awaiting illumination is homeo-
pathic posology. Today, in almost any seminar on 
homeopathy a blatant discrepancy can be experienced 
between a usually painstaking presentation, discussion, 
and explanation of a case history and its remedy and a 
relatively brief, casual, or even uneasy statement of the 
potency given- if it is mentioned at all. The shaky 
state of posology refiected in such an inconsistent 
behavior, however, has distinct but deep historical 
roots. 
As a rule, homeopathic doctrine is based on Samuel 
Hahnemann's written legacy: his published methodo-
logical writings, provings, and principles. In the case of 
quinquagintamillesimal (50,000) potencies, usually 
known as q-potencies in the German speaking world, 
and LM in English, a delay of nearly 80 years in the 
publication of Hahnemann's last work not only 
prevented its contemporary reception among his 
followers but allowed another tradition to rise, spread, 
and prevail until today. Since, throughout his life 
Hahnemann referred to and recommended c-potencies 
only, it was quite natural for his disciples to follow and 
extend this apparently ultimate and authorized path. 
Hence, for instance Clemens von Bönninghausen and 
Carroll Dunharn advocated the 200c, while James 
Tyler Kent introduced a scale of ultra-high millesimal 
potencies: m, xm, lm, cm, dm, mm, etc. Adherents of 
low potencies like Richard Hughes opposed this kind 
of development, but virtually all of them referred to the 
same ratio of potentization (1 : 100), ie c-potencies-
apart from some German homeopathic pharmacists 
who developed a modified scale of potentization ( d- or 
x-potencies, 1:10). 
This common denominator did not change even 
when Richard Haehl1 in 1921 and William Boericke2 in 
1922 published, in German and English respectively, 
for the first time, the sixth edition of Hahnemann's 
Organon of Medicine, whose manuscript had been 
completed in 1842. It contained Hahnemann's last 
legacy: the description of 50,000 potencies which, in 
the last 5 years of his life, he had found to be the 
'strongest and mildest, ie most perfect' preparations.3 
Amazingly, neither Haehl nor Boericke mentioned the 
new method of potentization in their prefaces (the 
publishers of these editions were the homeopathic 
pharmaceutical companies Willmar Schwabe and 
Boericke & Tafel). Although anyone who cared to do 
so was now able to read verbatim the revised Section 
270 of the Organon, nobody seemed to realize that it 
did not deal with c-potencies any more. 
Only in the 1950s did the Swiss homeopathic 
doctors, Rudolf Flury, Adolf Voegeli, Pierre Schmidt, 
and Jost Künzli von Fimmelsberg, start to draw the 
attention of their colleagues to the 50,000 potencies 
which from now on were called LM- or q-potencies.4 
Considering the predominance of the more than a 
hundred years old tradition of c-potencies, the echo 
within the homeopathic community was very weak. 
After all, acknowledgement of Hahnemann's unheard 
directions would have meant a significant change to 
practice with a completely new set of remedies. A 
simple way of escaping the dilemma was to question 
the authenticity of Haehl's edition, which was based 
only on a transcript of Hahnemann's manuscript. 
With the definitive text-critical edition of the original 
manuscript, published in 1992,5 this kind of pretext 
was no Ionger viable. Finally, backed by such an 
assurance, pharmaceutical companies like Gudjons in 
Germany embarked on the manufacture of authentic 
q-potencies and even to specialize in their production. 
Meanwhile also in other countries, an ever increasing 
proportion of homeopathic practitioners and patients 
are prescribing and using potencies prepared according 
to Hahnemann's last instructions. 
Given the trend in modern didactics to try to acquire 
knowledge by working out and solving concrete cases 
rather than by memorizing fixed rules or dogmas, it 
would be interesting to know how and when Hahne-
mann actually administered q-potencies in his own 
practice- instead of just having to rely on his 
statements in the Organon. The answer to this 
question, however, is hidden behind a host of 
difficulties including the time, capacity, and energy to 
read and analyze thousands of handwritten pages of 
Hahnemann's German-French case books of his last 
years in Paris. As it turns out, even there q-potencies 
cannot be easily identified by one distinguishing mark 
or labe!, but have tobe traced like a detective by means 
of assumptions, refiections, and hypotheses. 
Up to now, three different approaches have been 




that the sign of a small circle ( 0) indicates a 
q-potency;6 (2) Ubiratan Adler (1994) introduced 
clinical pharmaceutical criteria (low potencies in a 
sequence of gradually ascending degrees) to locate 681 
prescriptions of q-potencies in Hahnemann's case 
books;7 and (3) Luise Kunkle (2001) developed a 
theory according to which fractions like 1/190, 1/191, 
1/ 192, etc would be ciphers for q1, q2, q3 , etc.
8 
Prompted by a criticism by Kunkle of Adler's criteria 
according to which Hahnemann would have tried out 
not more than 27 prescriptions of q-potencies before 
completing his Organon manuscript in February 1842, 
Adler revised his initial criteria to include the 0 sign 
(as proposed by Handley), too. The result of this new 
approach can be appraised in this issue. Using the 
combined criteria Adler now identifies 1836 prescrip-
tions of q-potencies by Hahnemann during the years 
1837- 1843, comprising 35 different remedies in poten-
cies ranging from ql to q30. Apparently due to a 
misinterpretation of Kunkle's theory, her criteria were 
not integrated or followed up further. 
This is, in short, the state of the art of archival 
research on Hahnemann's use of q-potencies. Clearly, 
it raises a nurober of questions of another kindas well. 
Given the evidence and reality of q-potencies intro-
duced, administered, and recommended by the older 
Hahnemann, the homeopathic community is chal-
lenged to discuss which sources of its art or science 
are to be considered most valid: Hahnemann's direc-
tions, his followers' tradition, one's own experience, 
clinical evidence, sound reasoning, emotional intuition, 
creative innovation, etc? Since the majority of homeo-
paths today are bound by education and years of 
practice to 'good-old' c-potencies, in this case, Hahne-
mann's words alone will probably not convince them 
to give up a well-tried scale of potencies in favor of a 
Homeopathy 
supposedly better system that still suffers from a 
relative lag of experience of some 150 years. As far as 
homeopathy is considered a science, however, basic 
research and comparative clinical studies (and prov-
ings) should settle this conflict impartially. 
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